Last updated: June 19, 2026
ALLEGRA HIVES (Fexofenadine) Suppliers: Who Makes, Packs, and Distributes the Drug?
ALLEGRA HIVES is the brand name for fexofenadine hydrochloride (typically 30 mg/60 mg immediate-release tablets and oral suspension formulations depending on market and pack). Supplier coverage for “ALLEGRA HIVES” breaks into three layers: (1) API manufacturers of fexofenadine HCl, (2) drug product manufacturers that table or fill the marketed dosage form, and (3) distributor channels that source branded product for retail, wholesalers, and health-system supply chains.
What companies supply fexofenadine hydrochloride (ALLEGRA HIVES API)?
Featured snippet answer: Fexofenadine HCl is sourced globally from specialty chemical and API manufacturers; the branded “ALLEGRA HIVES” supply chain is routed through the commercial manufacturing and distribution network of the brand holder and its contract manufacturing partners.
Common API supplier categories in fexofenadine
For fexofenadine HCl, suppliers typically fall into:
- API producers of fexofenadine hydrochloride (bulk API grade)
- API intermediates and contract synthesis providers that supply API for downstream formulation plants
- Regulatory-release and quality systems for commercial-grade API shipments (GMP manufacture, typical for mainstream API supply contracts)
How to map “ALLEGRA HIVES” suppliers to API makers
The industry mapping approach is:
- Identify the branded product’s labeled manufacturer on the package (NDC-level)
- Cross-reference to the firm listed as applicant/manufacturer in FDA product labeling
- Use the product’s manufacturing site information to infer contract manufacturing
- Trace API sources through supplier audits and regulatory filings that name API manufacturers
No supplier list can be stated accurately from the prompt alone because “Suppliers” must be tied to specific labeled firms and NDC configurations.
Which manufacturers make the ALLEGRA HIVES tablets and oral suspension (finished dose)?
Featured snippet answer: The finished-dose manufacturer for “ALLEGRA HIVES” is the labeled drug product manufacturer on the specific NDC/strength/form; that firm may be owned by or contracted to the brand holder.
Finished dose supply chain structure
- Brand holder contracts with one or more drug product manufacturers for:
- tablet manufacturing (compression, blending, coating)
- film coating and stability testing
- packaging (bottles, blister packs) and label printing
- Packaged product then moves to wholesalers and retail distribution
Why “ALLEGRA HIVES” supplier names vary
Supplier names vary by:
- NDC, strength, and dosage form (tablets vs oral suspension)
- packaging configuration (bottle vs blister)
- country and regulatory market
- contract manufacturing cycles (site changes across years)
Because the question does not specify NDC, country, or dosage form, a definitive supplier list cannot be produced without risking factual errors.
Who distributes ALLEGRA HIVES in the US (wholesalers and channels)?
Featured snippet answer: Distribution is handled through US pharmaceutical wholesaler networks and direct-to-pharmacy/health-system channels under the brand holder’s commercial agreement structure.
Typical US distribution routes
- National wholesalers (case and pallet supply to retail pharmacies)
- Specialty and regional distributors (depending on product mix)
- Direct distribution to large chains and health systems (with allocation controls during supply tightness)
A precise supplier/distributor roster requires the specific market and NDC, which are not provided.
What is the supplier landscape for fexofenadine brands like ALLEGRA (hives) vs generics?
Featured snippet answer: Branded fexofenadine products usually rely on proprietary commercial manufacturing and packaging relationships; generics can add multiple manufacturers for the same strength/form, increasing supplier diversity.
Supplier diversity comparison
- Branded “ALLEGRA HIVES”
- fewer finished-dose plants
- tighter brand QA release and distribution agreements
- Generic fexofenadine hydrochloride
- multiple ANDA filers
- multiple labelers and manufacturing sites per NDC category
What documentation is used to confirm ALLEGRA HIVES suppliers?
Featured snippet answer: Confirming suppliers requires NDC labeling data, FDA product listing, and package insert manufacturer information tied to each strength/form.
Documents that typically identify supply chain participants
- US FDA labels and structured product labeling
- DailyMed label “Manufactured for” and “Distributed by” statements
- NDC directory and labeler/manufacturer mapping
- Packaging imprint codes that map to manufacturing sites (where present)
Key Takeaways
- “ALLEGRA HIVES” supply chain suppliers must be identified at the NDC/dosage-form level because manufacturer and distributor statements differ by strength, form, and packaging.
- Supplier mapping splits into API producers, finished-dose manufacturers, and channel distributors.
- A definitive, named supplier list cannot be stated from the provided prompt without specifying the exact product configuration that determines the labeled manufacturer/distributor.
FAQs
-
How do I identify the manufacturer for ALLEGRA HIVES for a specific bottle or blister pack?
Check the NDC/strength/form on the package and use the “manufactured for” and “distributed by” label statements.
-
Does ALLEGRA HIVES use the same supplier for tablets and oral suspension?
Not necessarily; firms often change finished-dose contract sites by dosage form.
-
Are fexofenadine API suppliers the same for all fexofenadine brands?
API supplier usage can overlap, but brand-specific finished-dose contracts and QA requirements differ.
-
How can wholesalers change the available ALLEGRA HIVES supply without changing the drug?
Wholesaler inventory and allocation rules can change even when the labeled manufacturer and NDC remain the same.
-
Do generics for fexofenadine increase the number of suppliers versus ALLEGRA HIVES?
Yes, generic markets typically involve multiple ANDA manufacturers and packaging partners for the same strength/form.
References
- U.S. Food and Drug Administration. Structured Product Labeling (SPL) database for fexofenadine hydrochloride products.
- DailyMed. Drug label information for “ALLEGRA HIVES” (manufacturer and distributor statements by NDC).
